Clinical Trial

GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

Recruiting
View on ClinicalTrials.gov →
Summary
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-15
Trial Details
NCT Number NCT07166133
Lead Sponsor W.L.Gore & Associates
Conditions Aortic Arch Dissection, Aortic Arch Aneurysm
Enrollment 125 participants
Start Date 2026-03-02
Primary Completion 2028-07 (estimated)
Study Completion 2036-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-12